Heart failure is a long-term condition that can greatly affect a person’s quality of life.
It happens when the heart cannot pump or fill with blood properly.
This causes fluid to build up in the body, especially in the lungs. When fluid collects in the lungs, people may feel breathless and weak, and often need urgent hospital care.
Traditionally, doctors rely on symptoms to decide when to adjust treatment. However, by the time symptoms appear, the condition may already be serious. A new study suggests that there may be a better way.
Researchers have developed a noninvasive device that can detect early signs of fluid buildup in the lungs.
The study, presented at the American College of Cardiology’s Annual Scientific Session, shows that this approach can significantly improve patient outcomes.
The device, called the CardioSet Edema Guard Monitor, measures something known as lung impedance. This refers to how easily electrical signals pass through lung tissue. When fluid increases, the signal changes. This allows doctors to detect problems much earlier than before.
In the study, 150 patients with heart failure with preserved ejection fraction were followed for over three years. This type of heart failure is common, especially in older adults, and can be difficult to manage.
Patients were divided into two groups. One group received usual care, while the other group had their treatment guided by the device. Doctors in the second group could see the device readings and adjust medications based on early signs of fluid buildup.
The results showed a major difference. Patients in the device group had far fewer hospital visits. Only 19 hospital events were recorded in this group, compared to 93 in the standard care group. This represents a 74% reduction.
The benefits went beyond hospital visits. The risk of death was also much lower in the group using the device. Overall death rates dropped by 60%, and deaths specifically caused by heart failure dropped by 74%.
These improvements are likely due to earlier and more frequent treatment adjustments. Doctors were able to respond before patients became seriously ill. This early intervention is key in managing chronic diseases like heart failure.
Another strength of the device is that it is simple and noninvasive. It can be used during regular clinic visits and may even be used at home in the future. This could make monitoring easier and more accessible for patients.
However, the study has some limitations. It was conducted at a single center, and the results need to be confirmed in larger, multi-center trials. Also, one of the researchers has a connection to the device company, which means independent studies are important.
Despite these limitations, the findings are encouraging. They suggest that monitoring technology can help doctors stay ahead of the disease instead of reacting to it.
In conclusion, this study shows that early detection of fluid buildup can greatly improve outcomes for people with heart failure. By using simple technology, doctors can reduce hospital visits, lower death rates, and improve quality of life.
The study was presented at the American College of Cardiology’s Annual Scientific Session.
This research is important because it focuses on prevention rather than treatment after the fact. It shows how small changes in monitoring can lead to big improvements in health. Future studies will help determine whether this approach can be used widely around the world.
If you care about heart health, please read studies about how eating eggs can help reduce heart disease risk, and herbal supplements could harm your heart rhythm.
For more health information, please see recent studies about how drinking milk affects risks of heart disease and cancer, and results showing strawberries could help prevent Alzheimer’s disease.
